DOJ, SEC Expand FCPA Probe into Eli Lilly
Pharmaceutical giant Eli Lilly revealed in a filing Monday that its activities in several countries are now under scrutiny. The Securities and Exchange Commission began investigating Lilly's operations in Poland in 2003.
To read more
Subscribe to Global Investigations Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Investigations Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10